Expression of circulating CD146 associated with endovascular dysfunction in adenine-induced chronic renal damage in rats using an EvaGreen real-time RT-PCR assay by P., Farah Dina et al.
ISSN: 1511-3701
Pertanika J. Trop. Agric. Sci. 34 (2): 381 - 391 (2011) © Universiti Putra Malaysia Press
Received: 2 September 2010
Accepted: 23 September 2010
*Corresponding Author
INTRODUCTION
The National Kidney Foundation Task Force 
on Cardiovascular Disease in Chronic Renal 
Disease reported patients with chronic kidney 
disease are at a higher risk of developing 
cardiovascular disease (CVD) (Levey et al., 
1998).  The evidence of the relationship between 
renal dysfunction and adverse cardiovascular 
(CV) events was first recognised in the dialysis 
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ABSTRACT
The integrity of the endothelial layer of the blood vessel, intima, is critical since damage can lead to 
atherosclerosis.  Assessment of its integrity is therefore very important although this can not be done through 
routine diagnostic analysis.  An alternative non-invasive method should be established to assess its integrity.  The 
objective of this study was to develop a quantitative real-time reverse transcriptase polymerase chain reaction 
(qRT-PCR) using an EvaGreen dye for the assessment of vascular endothelial damage-associated with chronic 
renal damage in rats via quantification of the expression level of CD146, which is one of the blood biomarkers 
of endovascular dysfunction and/or damage.  Comparison of the sensitivity of the EvaGreen qRT-PCR and the 
conventional RT-PCR was also performed in this study.  For this purpose, a total of 16 male Sprague Dawley 
rats were divided equally into two groups, namely the control and adenine.  Results showed that rats fed with 
diet containing 0.75% adenine for six consecutive weeks developed chronic renal damage through elevations 
in the blood urea nitrogen (BUN) and blood creatinine (Cr) levels, increased urine protein to creatinine ratio 
(UPC) and decreased creatinine clearance (CrCl).  The confirmatory diagnosis of chronic renal damage was 
made through gross and histopathological examinations of the kidneys.  The results were consistent with lesions 
of chronic renal damage.  The expression of circulating CD146 was mildly increased in rats with chronic 
renal damage analysed using the EvaGreen qRT-PCR or the conventional RT-PCR, suggesting a mild degree 
of endovascular damage.  The intensity of the EvaGreen qRT-PCR products, however, was brighter than the 
conventional RT-PCR, indicating that the EvaGreen qRT-PCR is more sensitive compared to conventional 
RT-PCR, which is further recommended for analysis of CD146 expression in rats.
Keywords: Adenine, CD146, vascular dysfunction and damage, chronic renal damage, real-time RT-
PCR, conventional RT-PCR
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patients who showed high incidence of CV death. 
Several studies have reported approximately 
50% of individuals with end stage renal disease 
(ESRD) die from CVD-related events, such as 
heart attacks (Foley et al., 1998; Herzog et al., 
1998; Tonelli et al., 2006).  The development 
of CVD is suggested as the result of endothelial 
dysfunction and excessive oxidative stress. 
Endovascular dysfunction is an early feature 
of vascular disease in different diseases, such 
as chronic renal failure, diabetes, hypertension, 
hypercholesterolaemia, and coronary heart 
disease.
CD146, a membrane glycoprotein, is 
expressed in all human endothelium or vessel 
calibres.  Expressed by the endothelial cells, 
it is one of the genes that is localised at the 
endothelial junction (Bardin et al., 1996; 2001). 
In blood, the vast majority of blood cells that 
express CD146 are lymphocytes (Duda et al., 
2006).  Hence, low level of the CD146 gene 
expression could be detected in healthy blood. 
Meanwhile, the increase in the number of 
circulating cells, including circulating endothelial 
cells (CECs) and lymphocytes expressing the 
membrane glycoprotein CD146, was observed 
in a wide variety of unhealthy conditions such 
as inflammatory, immune, infectious, neoplastic, 
and cardiovascular diseases which are likely to 
be evidence of profound vascular insult (Blann 
et al., 2005).  Koc et al. (2005) reported that 
elevation of CEC numbers conveys a risk of 
future vascular events.  Studies conducted by 
Bardin et al. (2003), Malyszko et al. (2004), 
Faure et al. (2006) and Sally et al. (2009) 
demonstrated that circulating CD146 and 
CD144 were significantly elevated in human 
patients with uraemic chronic renal failure. 
Those patients usually show various pathologies 
associated with endothelial dysfunction, such 
as acute coronary syndromes (Mallat et al., 
2000), preeclampsia (Bretelle et al., 2003) or 
antiphospholipid syndrome (Dignat-George 
et al., 2004).  The detection of circulating CD146 
in those studies was performed via several means 
or methods such as ELISA, flow cytometry and 
real-time RT-PCR assays.
The objectives of this study were to develop 
a quantitative real-time reverse transcriptase 
polymerase chain reaction (qRT-PCR) using an 
EvaGreen dye for the assessment of vascular 
endothelial damage-induced by chronic 
renal damage in rats via quantification of the 
expression level of CD146, and to compare the 




Both the control and Adenine groups equally 
comprised eight 6-week-old Sprague Dawley 
male rats.  The rats in the control group were 
fed with normal rat pellets and water ad libitum 
throughout the 10-week experimental period. 
Meanwhile, the rats in the Adenine group were 
fed with ground rat pellets that were mixed with 
0.75% Adenine (Sigma-Aldrich) and water ad 
libitum for 6 weeks (the treatment period), and 
this was continued with normal rat pellets and 
water ad libitum for 4 more weeks thereafter 
throughout the observation period.  The rats were 
daily observed for clinical signs of renal failure.
Blood and Urine Analyses
Blood creatinine (Cr) and blood urea nitrogen 
(BUN) were analysed fortnightly during the 
treatment period.  The blood samples were 
directly collected from the tail vein at weeks 
0, 2, 4, 6, 8, and 10, and immediately analysed 
using an Automated Dry Chemistry Analyser 
(scil Reflovet® Plus, Roche Diagnostics) as per 
manufacturer’s instruction.  Both the blood and 
12-hour urine samples were collected at the end 
of the experimental period.  Urine volume was 
measured using a standard method.  Serum Cr, 
urine Cr, and urine protein concentrations were 
analysed using an Automatic Biochemistry 
Analyser (Biorex, TRX7010, Manheim, Japan).
RNA Extraction from Fresh Whole Blood
The blood samples were taken from each rat via 
cardiac puncture at the end of the experiment. 
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RNA was extracted from the whole blood 
using a QIAamp RNA Blood Mini Kit from 
Qiagen (USA).  The optical density (OD) of the 
extracted RNA was determined by measuring 
the absorbance at A260/A280 nm using a 
spectrophotometer (Eppendorf, German) and 
kept in -80°C until reverse transcription for 
cDNA synthesis.
Conventional RT-PCR Assay for Amplification 
of CD146 and GADPH Genes
The extracted RNA was converted into cDNA 
using a GeneAmp RNA PCR Core Kit (Applied 
Biosystems, USA), as per manufacturer’s 
instruction.  The cDNA products were stored 
at -20°C.
Master mix for the conventional PCR was 
prepared using sterile deionised water with the 
total reaction mixture of 20 uL containing 2 mM 
MgCl2 solution, 1x PCR Buffer II, 200 uM for 
each dNTPs (Applied Biosystems, USA), 1.5 uM 
CD146/GAPDH forward and reverse primers 
(1st BASE, Malaysia), 0.05U AmpliTaq DNA 
polymerase (Applied Biosystem, USA), and 
2 uL of sample containing 3 - 4 ng of cDNA. 
The amplification of the cDNA via conventional 
PCR was performed using a conventional 
PCR machine (Little Genius, BIOER).  The 
amplification conditions were as follows: 1 cycle 
of 95°C for 2 minutes (predenaturation), 
followed by 30 cycles of 95°C for 30 seconds 
(denaturation), 51.2°C (for CD146) and 50.0°C 
(for GAPDH) for 30 seconds (annealing), 72°C 
for 30 seconds (extension), and 1 cycle at 72°C 
for 7 minutes for the final extension.
Meanwhile, the primers for the GADPH 
gene (designed using the Oligo Primer 
Analysis Software v.7) were: GAPDH forward: 
5 ’ -TGTGAACGGATTTGGCCGTA-3’ , 
and  GAPDH reve r se :  5 ’ -CATTTGAT 
GTTAGCGGGATC-3’.  The size of the 
amplification product is 240 bp (GenBank 
accession number: NM017008).  All the CD146 
amplification products were normalised with the 
GAPDH gene.
Real-time RT-PCR Assay for the Amplification 
of CD146 Gene
The same cDNA samples that were converted 
from the total RNA were used.  Meanwhile, the 
master mix for the qPCR was prepared with the 
total reaction mixture of 20 uL containing 10 uL 
ImmoMix™ (Bioline, USA), 1 uL EvaGreen™ 
Dye (Biotium, USA), 1.5 um CD146 forward 
and reverse primers (1st BASE, Malaysia), as 
well 2uL of sample containing 3 - 4 ng of cDNA 
mixed with sterile deionised water in a single 
qPCR tube for each reaction.  The amplification 
of CD146 gene was done using a real-time PCR 
machine (Biorad CFX96), with the following 
amplification conditions: 1 cycle of 94°C for 
15 minutes (predenaturation), followed by 35 
cycles of 94°C for 15 seconds (denaturation), 
51.2°C for 30 seconds (annealing), 72°C for 45 
seconds (extension).
The primers for CD146 gene used in this 
study were those previously described by Taira 
et al. (2004) and Hazilawati et al. (2010).  The 
size of the PCR products is 100 bp.
Gel Electrophoresis
The PCR products were electrophoresed at 80V 
for 60 minutes in 1.5% agarose gel, stained 
with 0.5 ug/mL ethidium bromide solutions 
for 15-20 minutes, and visualised under UV 
transillumination (Alpha Imager, GEL DOC). 
The intensity of the bands of CD146 and 
GADPH in the control and Adenine groups was 
also compared.
Gross Lesion and Histopathological 
Examination
All the rats were sacrificed at the end of the 
10-week experimental period.  Both the left 
and right kidneys were collected and fixed in 
10% formalin.  The kidneys were processed 
with a standard protocol for Haematoxylin and 
Eosin (H&E) staining for histopathological 
examination.
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Statistical Analysis
The results were analysed using SPSS version 
17.0 for ANOVA and differences at p<0.05 were 
considered as significant.
RESULTS AND DISCUSSION
Blood Urea Nitrogen (BUN) and Blood 
Creatinine (Cr)
Figs. 1 and 2 show the blood urea nitrogen 
(BUN), and blood creatinine (Cr) concentrations 
of the control and Adenine groups throughout 
the 10-week experimental period.  It was found 
that the baseline value for BUN and blood 
Cr concentrations of the control and Adenine 
groups were 9.33±0.57 mmoL/L and 7.97±0.63 
mmoL/L, respectively, and 44.20±0.00 umoL/L 
for both groups.  The rats in the Adenine group 
had gradual increase in the blood Cr and 
BUN concentrations throughout the treatment 
period.  The highest values were observed 
at week 6; BUN was significantly increased 
to 38.05±7.11 mmoL/L and blood Cr was 
significantly increased to 201.30±43.85 umoL/L. 
Those parameters were decreased about half of 
the peak values during the observational period, 
although it was still significantly higher than the 
control group and/or normal ranges.  A similar 
study conducted by Okada et al. (1999) showed 
Wistar rats were more susceptible to chronic 
renal failure induced by adenine.  Blood Cr and 
BUN levels in their study were higher than those 
obtained in this study, whereby they reported 
67% of the adenine-treated rats died of chronic 
renal failure during the study.  In this study, the 
mortality rate was 0%.
Urine Protein to Creatinine Ratio (UPC)  
and Creatinine Clearance (CrCl)
Figs. 3 and 4 show UPC and CrCl of the control 
and adenine-treated rats.  Even though BUN 
and blood Cr concentrations dropped during 
the observation period, albeit still significantly 
higher than the normal values, the UPC and 
CrCl results were consistent with the renal 
insufficiency.  The UPC of the control rats was 
3.38±1.61, while the UPC of the adenine-treated 
rats was 16.07±19.37, which was significantly 
five times higher than the control.
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Fig. 1: The BUN concentrations of the Adenine group were gradually increased from 
week 0 to 6 (treatment period), and decreased at weeks 8 and 10 (observation period*).  
The BUN results (weeks 2 to 10) for the rats in the Adenine group were significantly 
different at p<0.05 from those rats in the control group
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Fig. 2: The blood creatinine concentrations of rats in the Adenine group show a similar 
trend in their BUN concentrations.  The results (weeks 4 to 10) were significantly 
different at p<0.05 from those rats in the control group
The CrCl for the control and adenine groups 
were significantly different, with 59.72±38.30 
and 12.48±10.91 mL/hour, respectively.  It was 
clearly showed that the rats in the Adenine group 
were unable to remove creatinine in the body as 
















Fig. 3: The UPC of the rats in the Adenine 
group was significantly (p<0.05) increased  


















Fig. 4: The clearance of creatinine (CrCl) from 
the body through the urine of rats in the Adenine 
group was significantly (p<0.05) decreased 
compared to those rats in the control group.  The 
results were comparable to the blood creatinine 
concentrations of the rats shown in Fig. 2
Detection of Circulating CD146 via EvaGreen 
qRT-PCR and Conventional RT-PCR
In this study, the transcription of CD146 in the 
blood was determined by both the qRT-PCR and 
conventional RT-PCR assays. Other than the 
comparison of the threshold cycle (Ct) from the 
amplification graph of the control and adenine 
groups, the intensity of CD146 bands from the 
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Fig. 5: Bands of the GADPH amplification products (240 bp) of the control (C1 to C8) 
and chronic renal damage rats (A1 to A8) amplified using the conventional RT-PCR 
assay.  The amplications of the control rats are labelled as C1 to C8, whereas the 
amplications of the Adenine rats are labelled as A1 to A8.  The DNA markers (Bioline, 
UK) are in lanes 1 and 11.  Negative controls showed no amplification
EvaGreen qRT-PCR and the conventional RT-
PCR assays were also compared.
Figs. 5 and 6 show the amplification products 
of GAPDH and CD146 genes, respectively, from 
the control and adenine-treated rats amplified 
using the conventional RT-PCR.  All the rats 
in both groups had expressed the GAPDH 
gene (Fig. 5).  Meanwhile, the intensity of the 
bands was almost similar, indicating that the 
quality and quantity of the extracted RNAs were 
similar between the groups. The amplification 
of CD146 transcripts via the conventional 
method, however, was more difficult as both 
groups showed very faint bands, albeit the 
intensity of the bands was slightly brighter in 
the adenine group (Fig. 6).
Further investigation on the level of 
transcription of CD146 in the control and 
Adenine groups, via the EvaGreen qRT-PCR 
assay, revealed that the mean threshold cycle (Ct) 
of the adenine-treated rats was not significantly 
different from the control, 21.23 ± 0.38 (Adenine 
group) and 20.96 ± 0.79 (control group) (Fig. 7). 
The band intensity of the EvaGreen qRT-PCR 
products of the adenine-treated rats was slightly 
brighter and thicker than the control rats (Fig. 8), 
although the concentrations of the PCR products 
were almost comparable to the control (Fig. 8). 
This indicates that rats with chronic renal damage 
had a very mild increase in the expression of 
CD146 in the blood circulation, reflecting the 
dysfunction or damage of the endovascular wall. 
The findings of this study therefore suggested 
that the daily feeding of 0.75% adenine diet to 
rats for 6 weeks, followed by normal diet for 4 
more weeks after that might have not induced 
significant damage to the endothelial layer of the 
blood vessels.  Some previous studies reported 
that significant higher expression of CD146 has 
been observed in chronic renal failure patients 
analysed using ELISA (Baldin et al., 2003; 
Malyszko et al., 2004), flow cytometry (Faure 
et al., 2006) and also real-time RT-PCR assay 
(Sally et al., 2009).
A comparison of the intensity of bands 
between the conventional RT-PCR and the 
EvaGreen qRT-PCR assays clearly showed 
that the EvaGreen qRT-PCR assay is far more 
sensitive as compared to the conventional RT-
PCR assay (Figs. 6 and 8).  The results are in 
agreement with the findings reported by Di Trani 
et al. (2006) and Gurukumar et al. (2009) for the 
Expression of Circulating CD146 Associated with Endovascular Dysfunction
387Pertanika J. Trop. Agric. Sci. Vol. 34 (2) 2011
Fig. 6: Bands of CD146 amplification products (100 bp) of control (C1 to C8) and chronic 
renal damage rats (A1 to A8) amplified using the conventional RT-PCR assay. Amplicons of 
control rats are labeled as C1 to C8 and amplicons of Adenine rats are labeled as A1 to A8.  
DNA markers (Bioline, UK) are on lanes 1 and 11.  Negative controls show no amplification
detection of avian influenza and dengue viruses, 
respectively.
Gross and Histopathological Findings  
of the Kidneys
Fig. 9 shows gross and histopathological lesions 
of the kidneys of rats with chronic renal damages. 
All the rats that were treated with adenine had 
enlarged kidneys (Fig. 9A[a]) with generalised 
yellowish discolouration (stone like colour) of 
the renal parenchyma, which were consistent 
with severe renal damage.  Microscopically, the 
kidneys had abnormal glomeruli (Fig. 9B[c]), 
crystal of adenine in the interstitial tissues 
(Fig. 9B[d]), infiltration of inflammatory cells 
in the interstitial tissues (Fig. 9B[e]), infiltration 
of inflammatory cells in the renal tubules 
(Fig. 9C[f]), necrotic cells (Fig. 9D[g]), tubular 
dilatation (Fig. 9D[h]), interstitial fibrosis (Fig. 
9E[i]) and protein casts in the renal tubules (Fig. 
9F[j]).  The results were comparable to those 
of the previous reports (Yokozawa et al., 1986; 
Tamagaki et al., 2005).
Several studies, via ultrasound, vascular 
markers’ measurements, vessel wall movement 
detector and occlusion plethysmography, have 
suggested that chronic renal failure is associated 
with impaired endothelial function (Guldener 
et al., 1998; Bolton et al., 2000).  However, 
the precise mechanisms of chronic renal 
failure that induces endovascular dysfunction 
are still unclear.  Several possibilities have 
been proposed, and these include oxidative 
stress-related accumulation of uraemic toxins 
and chronic inflammation (Stenvinkel et al., 
1999).  Other possible causes of endovascular 
dysfunction are accumulation of oxidised 
low-density lipoprotein (oxLDL) (Stenvinkel 
et al., 1999) and elevation of asymmetric 
dimethylarginine (ADMA), a competitive 
inhibitor of endothelial nitric oxide (NO) 
production (Zoccoli et al., 2001).
CONCLUSION
In conclusion, the study has demonstrated 
that circulating CD146 is mildly expressed 
in rats with chronic renal damage, and the 
EvaGreen qRT-PCR assay is more sensitive 
compared to conventional RT-PCR assay, and it 
is thus recommended for the analysis of CD146 
expression in rats with endovascular dysfunction 
and/or damage.
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Fig. 8: Bands of CD146 amplification products (100 bp) amplified using the EvaGreen 
qRT-PCR assay.  The amplifications of the control rats are labelled as C1to C8, whereas 
the amplications of the Adenine rats are labelled as A1 to A8.  The DNA markers 
(Bioline, UK) are given in lanes 1 and 11.  Negative controls show no amplification
Fig. 7: Amplification graph of CD146 of the control (C1 to C8) and adenine-treated rats 
(A1 to A8).  The melting curve peak for each sample clearly showed that all the amplified 
genes are products specific of CD146 with the melting temperature of 80.5°C±1.0°C
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Fig. 9(A) a: Enlarged kidney with generalised yellowish discolouration, b: normal kidney; 
(B) c: abnormal glomeruli, d:adenine crystals, e: infiltration of inflammatory cells in the 
interstitial tissues; (C) f: infiltration of inflammatory cells in the renal tubule; (D) g:necrotic 
cells, h: tubular dilatation; (E) i: interstitial fibrosis; (F) j: protein casts
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